Format

Send to

Choose Destination
J Intern Med. 2008 Dec;264(6):514-27. doi: 10.1111/j.1365-2796.2008.02029.x.

Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.

Author information

1
Department of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital, Stockholm, Sweden. karin.ekstrom.smedby@ki.se

Abstract

As specific autoimmune disorders now constitute established risk factors for malignant lymphomas, we describe this association. We review reported risk levels, risk determinants, lymphoma subtypes and biological mechanisms in autoimmunity/inflammation, emphasizing on recent findings. Whilst numerous reports describe average lymphoma risks in large patient groups, there's a recent shift of focus to risk determinants and the role of inflammatory activity. Studies highlight associations with diffuse large B-cell lymphoma, apart from lymphoma development in target organs of inflammation. Future studies of high-risk patient subsets using detailed assessments of autoimmunity/inflammation and lymphoma may give important clues to lymphomagenesis.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center